Article
A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding.
Biochimica et biophysica acta - 1 Jul 2010
Child Emma S, Hendrychová Tereza, McCague Karen, Futreal Andy, Otyepka Michal, Mann David J
Abstract excerpt
Cyclin-dependent kinase 2 (cdk2) is a central regulator of the mammalian cell cycle. Here we describe the properties of a mutant form of cdk2 identified during large-scale sequencing of protein kinases from cancerous tissue. The mutation substituted a leucine for a proline in the PSTAIRE helix, the central motif in the interaction of the cdk with its regulatory cyclin subunit. We demonstrate that whilst the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
